StudyFinder

A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature (ISS)

Status: Recruiting

This research is being done to learn if a study drug called vosoritide can help children who are shorter than should be for their age to grow.

I'm interested

Sex: Male or Female
Age Group: Up to 18 years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• 3 to 10 years old if a girl
• 3 to 11 years old if a boy
• have short stature compared to others of the same gender and age with no known cause
• able to move and stand without help
Exclusion Criteria:

• known chromosomal imbalance or genetic variant causing short stature syndrome
• previous treatment with a growth promoting agent
Conditions:

Diabetes & Endocrine, Rare Diseases

Keywords:

idiopathic short stature, ISS, short

Study Contact: Cydney Coleman - colem520@umn.edu
Principal Investigator: Brad Miller, MD, PhD
Phase: PHASE2
IRB Number: STUDY00023763
See this study on ClinicalTrials.gov

Back